Deal overview
| Target | QIAGEN NV |
|---|---|
| Bidder | EQT AB |
| Price | £90.00 Full version or £25.00 Light version |
| Publication Date | Oct 21, 2026 |
| Abstract | On 21 October 2026, the Swedish-quoted private markets investment group EQT AB ("EQT"), acting through Crown NL Bidco B.V. ("Crown NL Bidco"), a holding company indirectly controlled by the EQT XI fund ("EQT Private Equity"), announced a recommended all-cash voluntary public offer for the quoted Dutch molecular sample and assay technologies group QIAGEN N.V. ("QIAGEN"). EQT ... |
| Number of pages (Full version) | 9 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2026 M&A Monitor Limited
